More generally CCL21 may work in synergistic and redundant manners with other chemokines produced by lymphatic endothelium to facilitate lymphatic invasion by tumor cells that over-express chemokine cognate receptors [15,18]. The gene discussed is CCL21; the disease is neoplasm.